Financhill
Back

SPDR® S&P Health Care Services ETF Vs. Range Cancer Therapeutics ETF Industry Stock Comparison

Buy
66

XHS
SPDR® S&P Health Care Services ETF

Last Price:
97.06
Seasonality Move:
6.49%
Sell
49

CNCR
Range Cancer Therapeutics ETF

Last Price:
14.00
Seasonality Move:
2.55%
Buy
66
SPDR® S&P Health Care Services ETF (XHS) is a Buy

Is SPDR® S&P Health Care Services ETF a Buy, Sell or Hold?

  • The current SPDR® S&P Health Care Services ETF [XHS] share price is $97.82. The Score for XHS is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
  • XHS is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
49
Range Cancer Therapeutics ETF (CNCR) is a Sell

Is Range Cancer Therapeutics ETF a Buy, Sell or Hold?

  • The current Range Cancer Therapeutics ETF [CNCR] share price is $13.79. The Score for CNCR is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
  • CNCR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

XHS Stock Price Chart

What is SPDR® S&P Health Care Services ETF's stock price today?

  • The SPDR® S&P Health Care Services ETF share price today is $97.82
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and XHS is experiencing buying pressure, which is a positive indicator for future bullish movement.

CNCR Stock Price Chart

What is Range Cancer Therapeutics ETF's stock price today?

  • The Range Cancer Therapeutics ETF share price today is $13.79
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CNCR is experiencing selling pressure, which indicates risk of future bearish movement.

XHS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0 Sell
Relative Strength Index (14 RSI): 59.47 Buy
Chaikin Money Flow: 980 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (92.61 - 96.53) Buy
Bollinger Bands (100): (93.13 - 97.75) Buy

CNCR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.42 Sell
Relative Strength Index (14 RSI): 40.74 Sell
Chaikin Money Flow: -17976 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (13.81 - 15.43) Sell
Bollinger Bands (100): (14.1 - 15.46) Sell

XHS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 93.79 Buy
20-day SMA: 94.84 Buy
50-day SMA: 95.11 Buy
200-day SMA: 92.96 Buy
8-day EMA: 95 Buy
20-day EMA: 94.82 Buy
50-day EMA: 94.99 Buy
200-day EMA: 93.16 Buy

CNCR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 13.55 Buy
20-day SMA: 14.53 Sell
50-day SMA: 14.82 Sell
200-day SMA: 15.04 Sell
8-day EMA: 13.77 Buy
20-day EMA: 14.27 Sell
50-day EMA: 14.62 Sell
200-day EMA: 14.55 Sell

SPDR® S&P Health Care Services ETF Earnings Growth & XHS Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Range Cancer Therapeutics ETF Earnings Growth & CNCR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

SPDR® S&P Health Care Services ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Range Cancer Therapeutics ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):